GTCM
RMD icon

Gyon Technologies Capital Management’s ResMed RMD Stock Holding History

Gyon Technologies Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,695
Closed -$702K – 520
2021
Q4 		$702K Buy
2,695
+1,144
+74% +$297K 0.13% 218
2021
Q3 		$409K Buy
+1,551
New +$424K 0.11% 229

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Gyon Technologies Capital Management's RMD Position: Q1 2022 in Review

Gyon Technologies Capital Management sold out of ResMed (RMD) in Q1 2022, closing a stake of 2,695 shares — an estimated $702K sold.

Gyon Technologies Capital Management first reported a position in RMD in Q3 2021 and held it in 2 quarters. The position peaked at $702K in Q4 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

  • Gyon Technologies Capital Management reported no remaining ResMed position as of Q1 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 2,695 ResMed shares in Q1 2022, an estimated $702K.
  • Gyon Technologies Capital Management first reported a position in ResMed in Q3 2021 and held it in 2 quarters.
  • Gyon Technologies Capital Management's ResMed position peaked at $702K in Q4 2021.
  • 682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2022, filed 12 May 2022.